Table 4.

ALT and AST parameters measured in serum (mean ± SEM).

Groups	n	AST (U/L)	ALT (U/L)
Control	8	21.20 ± 6.95∗∗	20.94 ± 7.49∗∗
Model	8	52.15 ± 14.10	58.55 ± 13.45
Salidroside	8	39.02 ± 9.30∗	43.95 ± 12.31∗∗
Rosiglitazone	8	45.33 ± 9.12	48.26 ± 8.27∗

 ^∗∗P < 0.01, ^∗P < 0.05versus model group.